AQMS stock forecast shows a cautious bullish trend, with shares trading near $1.02 on increased volume. Analysts project potential upside if quarterly revenue growth exceeds 15% YoY, driven by demand in battery recycling technology. Pros: If Aqua gets just a small piece of this burgeoning pie, it could send AQMS rocketing higher. That may be what H.C. Wainwright’s Amit Dayal may be thinking, who believes AQMS could hit $4 . Promising penny stock picks? Indeed! Relevance: Fundamentally, Eyenovia will be looking to create a modest niche within the massive ophthalmology industry. According to Data Bridge Market Research, the underlying global sector could expand at a CAGR of 6.4% from 2023 to 2030. At the forecast culmination, the valuation might hit nearly $84.66 billion. Last year, the industry was wroth $51.5 billion. And with Eyenovia only carrying a market cap of $78.3 million, it’s a tempting prospect. AQMS stock forecast models indicate a 12% potential upside in Q3, based on projected increases in recycling plant output and commodity prices.
